Horizon Therapeutics Public Ltd Co Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Horizon Therapeutics Public Ltd Co quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was $127M, a 108% increase year-over-year.
  • Horizon Therapeutics Public Ltd Co Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was $438M, a 42.7% decline year-over-year.
  • Horizon Therapeutics Public Ltd Co annual Net Income (Loss) Attributable to Parent for 2022 was $521M, a 2.43% decline from 2021.
  • Horizon Therapeutics Public Ltd Co annual Net Income (Loss) Attributable to Parent for 2021 was $534M, a 37.1% increase from 2020.
  • Horizon Therapeutics Public Ltd Co annual Net Income (Loss) Attributable to Parent for 2020 was $390M, a 32% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $438M $127M +$66.1M +108% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $372M $54.7M -$150M -73.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-08-08
Q4 2022 $521M $120M -$52.8M -30.5% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $574M $136M -$191M -58.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $765M $61M -$97.1M -61.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $862M $204M +$328M Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-08
Q4 2021 $534M $173M -$17.4M -9.12% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $552M $327M +$33.7M +11.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $518M $158M +$238M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-02
Q1 2021 $280M -$123M -$110M -808% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-02
Q4 2020 $390M $191M -$402M -67.9% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 $792M $293M +$275M +1506% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $517M -$80M -$74.9M -1463% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-03
Q1 2020 $592M -$13.6M +$19.3M +58.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-03
Q4 2019 $573M $593M +$491M +483% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 $81.9M $18.2M -$15.1M -45.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 $97M -$5.12M +$19.6M +79.3% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 $77.4M -$32.9M +$116M +77.9% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 -$38.4M $102M +$140M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$178M $33.4M +$97.1M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 -$275M -$24.8M +$185M +88.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 -$460M -$149M -$58.3M -64.5% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 -$402M -$38.2M +$91M +70.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$493M -$63.7M -$57.9M -986% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$435M -$209M -$224M -1497% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$210M -$90.3M -$44.9M -99% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$166M -$129M -$153M -639% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 -$12.3M -$5.87M -$9.15M -279% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 -$3.15M $15M -$16.8M -52.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $13.7M -$45.4M -$25.9M -132% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $39.5M $24M +$55.6M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 -$16.1M $3.28M +$1.21M +58.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$17.3M $31.8M +$59.6M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$76.9M -$19.6M +$187M +90.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$264M -$31.6M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $2.06M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$27.8M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$206M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q3 2011 -$17.2M -$4.74M -38% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-14
Q2 2011 -$11.6M -$18.5M -269% Apr 1, 2011 Jun 30, 2011 10-Q 2011-09-02
Q3 2010 -$12.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $6.88M Apr 1, 2010 Jun 30, 2010 10-Q 2011-09-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.